Literature DB >> 10520010

A novel BCR-ABL transcript e2a2 in a chronic myelogenous leukaemia patient with a duplicated Ph-chromosome and monosomy 7.

E O Leibundgut1, M Jotterand, V Rigamonti, V Parlier, D Mühlematter, A Tobler, M Solenthaler.   

Abstract

A novel BCR-ABL transcript was detected by multiplex RT-PCR in a patient with Philadelphia chromosome (Ph) positive chronic myelogenous leukaemia (CML) in accelerated phase. Sequencing of the aberrant transcript revealed an in-frame e2a2 fusion that included a 9 basepairs insertion. Cytogenetic analysis showed t(9;22), an additional Ph chromosome and monosomy 7. The clinical course was dismal: therapy was poorly tolerated, and the patient died in blast crisis 10 months after diagnosis. These data support the association of additional Ph and monosomy 7 with poor prognosis and suggest that the novel e2a2 BCR-ABL transcript may be related to an aggressive clinical course.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10520010     DOI: 10.1046/j.1365-2141.1999.01640.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.

Authors:  Dushyant Verma; Hagop M Kantarjian; Dan Jones; Rajyalakshmi Luthra; Gautam Borthakur; Srdan Verstovsek; Mary Beth Rios; Jorge Cortes
Journal:  Blood       Date:  2009-06-16       Impact factor: 22.113

2.  Novel BCR-ABL1 fusion and leukemic mutations of SETBP1, PAX5, and TP53 detected by next generation sequencing in chronic myeloid leukemia.

Authors:  Shuang Fu; Yanping Hu; Yu Fu; Fang Chen; Xuan Liu; Minyu Zhang; Xiaohui Wang; Shichun Tu; Jihong Zhang
Journal:  Cancer Biol Ther       Date:  2016-09-10       Impact factor: 4.742

3.  A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia.

Authors:  Xiaodong Lyu; Jingke Yang; Xianwei Wang; Jieying Hu; Bing Liu; Yu Zhao; Zhen Guo; Bingshan Liu; Ruihua Fan; Yongping Song
Journal:  Mol Cytogenet       Date:  2016-06-27       Impact factor: 2.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.